More NewsRead More
Mirati Therapeutics Reports First Quarter 2015 Financial Results and Provides Business Update
May 06, 2015
Mirati Therapeutics Reports Fourth Quarter and Full Year 2014 Financial Results and Provides Business Update
March 11, 2015
Mirati Therapeutics Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares
February 03, 2015
Mirati Therapeutics Prices Public Offering of Common Stock
January 29, 2015
Mirati Therapeutics Doses First Patient in Phase 2 Study of Mocetinostat in Bladder Cancer Patients with Genetic Alterations of CREBBP and EP300
January 07, 2015
Mirati Therapeutics Doses First Patient in Investigator-Sponsored Phase 2 Study of Mocetinostat in Non-Hodgkin's Lymphoma
January 06, 2015
from Market News Video
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here